| Always Remission | Some Remission | No Remission | Significance |
---|---|---|---|---|
(n = 68) | (n = 376) | (n = 308) |  | |
Females (%) | 34 (50%) | 299 (80%) | 246 (80%) | P < 0.001* |
Caucasian Ethnicity (%) | 58 (85%) | 287 (76%) | 195 (63%) | P < 0.001* |
Black African/Caribbean Ethnicity (%) | 1 (2%) | 37 (10%) | 62 (20%) | P < 0.001* |
Initial Mean Age In Years (SD) | 54 (16) | 55 (15) | 56 (14) | NS** |
Initial Disease Duration In Years (SD) | 5 (5) | 10 (9) | 12 (11) | P = 0.003** |
Initial Mean DAS28 (SD) | 1.65 (0.65) | 3.48 (1.32) | 4.65 (1.19) | P < 0.001** |
Overall Mean DAS28 (SD) | 1.57 (0.45) | 3.06 (0.71) | 4.47 (0.82) | P < 0.001** |
Any Flares (%) | 27 (40%) | 266 (71%) | 194 (63%) | P < 0.001* |
Overall Mean EQ5D-3 L (SD) | 0.77 (0.17) | 0.58 (0.24) | 0.38 (0.28) | P < 0.001** |
Initial Mean HAQ (SD) | 0.31 (0.50) | 1.06 (0.81) | 1.58 (0.81) | P < 0.001** |
Overall Mean HAQ (SD) | 0.31 (0.45) | 1.03 (0.70) | 1.66 (0.67) | P < 0.001** |
HAQ Below 0.50 On One Or More Occasion (%) | 58 (85%) | 180 (48%) | 56 (18%) | P < 0.001* |